top of page
Screenshot 2023-06-13 180949.png
  • Writer's pictureThe Beagle

Over 70 and testing positive for COVID-19 can now access antiviral medicines

If you're over 70 and test positive for COVID-19 you can now access antiviral medicines to help reduce the severity of your illness. Antivirals reduce the risk of severe disease and hospitalisation from COVID-19.

People aged 50 years and older with two or more risk factors for severe disease and Aboriginal or Torres Strait Islander people aged 30 years and older with two or more risk factors for severe illness are also now eligible. Immunocompromised people over 18 may also be eligible.

COVID-19 oral antiviral treatments cost less than $10 for concession card holders, or around $45 for everyone else who is eligible.

Antiviral medicines only work within the first few days of symptom onset, so it’s critical that you get tested as soon as you feel unwell.

People who are at higher risk of severe illness should get a PCR test as they’re more accurate. If you can’t get a PCR test result quickly, it’s critical that you do a rapid antigen test while you wait for your PCR test result.

If you test positive on a rapid antigen test, don’t forget to register your test result with Service NSW immediately so you can be connected to the right care if you need it.

If you're at higher risk of serious illness from COVID-19, talk to your doctor about antivirals and make a plan for treatment options if you test positive for COVID-19.

If you have symptoms of COVID-19 or any concerns and are unable to get in touch with your GP, you can call Healthdirect 24/7 on 1800 022 222 or the NSW Health Flu and COVID-19 Care at Home Support Line on 1800 960 933.

NOTE: Comments were TRIALED - in the end it failed as humans will be humans and it turned into a pile of merde; only contributed to by just a handful who did little to add to the conversation of the issue at hand. Anyone who would like to contribute an opinion are encouraged to send in a Letter to the Editor where it might be considered for publication

bottom of page